Cilcare
Patricia Machado is an accomplished professional in the field of drug discovery and development, currently serving as the Early Drug Development and Pipeline Director at Cilcare. In addition to this role, Machado operates as an independent consultant specializing in drug discovery and development. Previous experience includes significant positions at Servier, where responsibilities encompassed serving as Head of Cell Sciences Research/Project Leader, Research Team Leader, and Translational Project Leader. Additionally, Machado has contributed to research efforts at Pfizer and Ecole Normale Supérieure. Patricia Machado holds an Executive MBA in General Management from IAE Paris - Sorbonne Business School, obtained between September 2021 and June 2023, along with training in Process Com I and II from 2018 to 2020.
This person is not in any teams
Cilcare
CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, synaptopathy, ototoxicity, sensorineural hearing loss and tinnitus. CILCARE Therapeutics has forged a portfolio of proprietary drug candidates and co-developed programs, while pioneering an unprecedented clinical approach to developing compounds targeting cochlear synaptopathy. CILCARE Auditory Analytics aims to position hearing as a key asset of preventive medicine and global healthcare monitoring. We aim to utilize patients' auditory measurements to define digital auditory signatures that will serve to characterize different forms of hearing impairments or other pathologies with precision.